Massachusetts offers perhaps the most attractive environment for biopharmaceutical research and development in the world, and is fast closing the gap with its rival supercluster in California.
Despite headwinds such as the NAFTA renegotiations, Mexico’s steel sector is seeing large investments by the likes of Ternium and ArcelorMittal, and is moving up the value chain, driven by a booming automotive sector.
Ranked the top destination for mineral exploration investment by the Fraser Institute in 2016, Saskatchewan has held strong ties to the mining sector for many years.
Mexican foundries are struggling to keep up with the demand from the country’s rapidly growing automotive industry.
Despite a gap between industry size and apparent attractiveness, Manitoba has the makings for long-term success.
As India’s domestic pharmaceutical market becomes increasingly crowded and the industry as a whole continues along the path of globalization, expansion of geographic presence and diversification of customer portfolios is a core focus for most companies.
